Medicine and Dentistry
Pheochromocytoma
100%
Glial Cell Line Derived Neurotrophic Factor
100%
Von Hippel-Lindau Disease
85%
Gene
57%
Neoplasm
28%
Ligand
28%
Pathogenesis
28%
Multiple Endocrine Neoplasia Type II
28%
Somatic Mutation
28%
Exon
28%
Glial Cell Line Derived Neurotrophic Factor Receptor
28%
Receptor
14%
Protein Tyrosine Kinase
14%
Diseases
14%
Malignant Neoplasm
14%
Clear Cell Renal Cell Carcinoma
14%
Missense Mutation
14%
Tumor Suppressor Gene
14%
Somatics
14%
Germline Mutation
14%
Proto Oncogene
14%
Ligand Binding
14%
Cancer Syndrome
14%
Germ Line
14%
Neurofibromatosis Type I
14%
Gene Amplification
14%
Analysis
14%
Family
14%
Biochemistry, Genetics and Molecular Biology
Glial Cell Line-Derived Neurotrophic Factor
100%
Von Hippel-Lindau Disease
85%
Nested Gene
42%
Mutation
28%
Somatic Mutation
28%
Receptor Tyrosine Kinase
14%
Candidate Gene
14%
Germline Mutation
14%
Missense Mutation
14%
Gene Amplification
14%
Sample
14%
RET Proto-Oncogene
14%
Immunology and Microbiology
Glial Cell Line Derived Neurotrophic Factor
100%
Tumor Suppressor Gene
57%
Gene
42%
Exon
28%
Mutation
28%
Somatic Mutation
28%
Carcinoma Cell
14%
Ligand Binding
14%
Missense Mutation
14%
Germ Line
14%
Gene Amplification
14%
Germline Mutation
14%
Sample
14%
Neuroscience
Glial Cell Line-Derived Neurotrophic Factor
100%
Gene
42%
Ligand
28%
Endocrine Neoplasia
28%
Exon
28%
Glial Cell Line Derived Neurotrophic Factor Receptor
28%
Eicosanoid Receptor
14%
Missense Mutation
14%
Somatic
14%
Receptor Tyrosine Kinase
14%
Ligand Binding
14%
Neurofibromatosis
14%
Gene Amplification
14%
RET Proto-Oncogene
14%
Agricultural and Biological Sciences
Glial Cell Line-Derived Neurotrophic Factor
100%
Genes
42%
Mutation
28%
Somatic Mutation
28%
Receptor Tyrosine Kinase
14%
Receptors
14%
Missense Mutation
14%
Germ Cell
14%
RET Proto-Oncogene
14%
Gene Amplification
14%